NEW YORK (GenomeWeb News) - Regeneron Pharmaceuticals has teamed with Geisinger Health System of Pennsylvania in a project that will use genomic analysis to study 100,000 patients with the aim of improving drug development and patient care capabilities, the partners said on Monday.

Regeneron will conduct its end of the partnership out of a new subsidiary, the Regeneron Genetics Center, located in Tarrytown, NY.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.